Accessibility Menu
Canopy Growth logo

Canopy Growth(NASDAQ) CGC

Market Cap$431.50MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2014)-97%
5 Year-99%
1 Year-32%
1 Month+7%
$1.00
-1.96%
-0.02Today
After hours$1.00+$0.00 (+0.00%)
Canopy Growth last closing stock price
MetricPriceDate
Last closeUSD 1.022026-08-14
Canopy Growth stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+5.14%USD 0.972026-08-07
1 month+7.03%USD 0.952026-07-15
3 month-1.92%USD 1.042026-05-15
Year to date-10.53%USD 1.142025-12-31
1 year-31.54%USD 1.492025-08-14
3 year-73.53%USD 3.852023-08-15
5 year-99.44%USD 180.602021-08-13
Since inception-96.91%USD 33.002014-04-07

Canopy Growth Financials at a Glance

Market Cap

$431.50MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$321.37M

Net Income (TTM)

-CA$259.27M

EPS (TTM)

-$0.45

P/E Ratio

-2.26

Dividend

$0.00

Beta (Volatility)

1.99 (High)

Price

$1.00

Volume

4,861,919.212

Open

$1.00

Previous Close

$1.00

Daily Range

$0.99 - $1.04

52-Week Range

$0.84 - $2.38

Estimated Earnings Date

Nov 6, 2026

CGC News

GettyImages-1335504645

Curaleaf Wants to Buy Aurora Cannabis for $272 Million. Is Canopy Growth the Next Marijuana Takeover Target?

Jeff SiegelAug 16, 2026
A glass of beer sitting on a table.

Best Beer Stocks to Buy in 2026 and How to Invest in Them

Jeremy BowmanAug 14, 2026
A person in a greenhouse.

Will Canopy Growth Get Acquired?

David Jagielski, CPAAug 13, 2026
A cannabis leaf on top of a $100 bill.

5 Best Cannabis ETFs for 2026 and How to Invest

Keith SpeightsAug 12, 2026
GettyImages-1197802179(1)

Canopy Growth: Penny Stock Purgatory -- or Cannabis Rebound in the Making?

Jeff SiegelAug 11, 2026
22_08_03 A person in a cannabis marijuana grow house _MF Dload

Why Rescheduling Might Not Move Canopy Growth's Stock as Much as You Think

Reuben Gregg BrewerAug 8, 2026
GettyImages-1477090373-1200x800-5b2df79

Thinking About Buying Canopy Growth? You May Want to Wait for This 1 Thing to Happen First.

Thomas NielJul 25, 2026
Smiling person in a grow room full of marijuana plants

President Trump's Major Marijuana Move: What It Means for Canopy Growth, Green Thumb, and Tilray

Eric VolkmanJul 17, 2026
Page 1

CGC: Motley Fool Moneyball Superscore

30

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Canopy Growth

Canopy Growth Corporation helps people find relief using cannabis. It makes products for medical and recreational needs. The company serves customers in Canada and Germany.

What Is in the Stash?

  • Cannabis Segment: Diverse range of flower, oils, and edibles for various consumer uses.
  • Storz & Bickel: High-end vaporizer devices manufactured with rigorous safety and performance certifications.
  • Adult-Use Brands: Consumer labels like Tweed and 7ACRES serving the Canadian adult market.
  • Medical Services: Network of clinics providing cannabis access to patients across Canada and internationally.

Cultivating New Markets

  • Acquired MTL Cannabis Corp. on March 16, 2026, to expand cultivation genetic capabilities.
  • Established Canopy USA in Oct. 2022 to prepare for United States market entry.
  • Finalized the acquisition of Acreage Holdings on Dec. 9, 2024, to build U.S. presence.
  • Expanded international medical sales into Germany and Poland during the first quarter of fiscal 2027.

A Different Kind of Greenhouse

Canopy Growth uses an asset-right model that focuses on driving efficiency through regional partnerships. This approach limits direct ownership of facilities to lower fixed costs and improve returns.

Measuring the Harvest

  • Net revenue was $81.2 million in the first quarter of fiscal 2027, up 13% year over year.
  • Net loss narrowed to $14.6 million in the first quarter of fiscal 2027.
  • Gross margin reached 27% in the first quarter of fiscal 2027, up from 25% year over year.
  • Cash and cash equivalents totaled $336.6 million as of June 30, 2026.

The Final Word

Canopy Growth has evolved from a broad producer into a focused brand house with a leaner operating structure. The company maintains its position in Canada while building a strategic bridge to the United States market.

AI Generated • Aug 7, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

1,128

CEO

Luc Mongeau

Website

www.canopygrowth.com

Headquarters

Smiths Falls, ON K7A 0A8, CA

CGC Financials

Key Financial Metrics (TTM)

Gross Margin

22.87%

Operating Margin

-46.89%

Net Income Margin

-73.95%

Return on Equity

-29.85%

Return on Capital

-7.49%

Return on Assets

-21.43%

Earnings Yield

-44.25%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$431.50MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

423.04M

Volume

4.86M

Avg. Volume

5.06M

Financials (TTM)

Gross Profit

CA$81.86M

Operating Income

-CA$102.63M

EBITDA

-CA$188.19M

Operating Cash Flow

-CA$78.48M

Capital Expenditure

-CA$5.20M

Free Cash Flow

-CA$83.68M

Cash & ST Invst.

CA$341.68M

Total Debt

CA$277.33M

Canopy Growth Performance Analysis

Canopy Growth annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31CAD 251,914,041-38.1%
20242024-03-31CAD 220,299,074-12.5%
20252025-03-31CAD 193,391,074-12.2%
20262026-03-31CAD 205,921,2766.5%
Canopy Growth sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-30-7.6%
Q32025-12-3153.4%
Q42026-03-31-30.3%
Q12026-06-3013.9%
Canopy Growth annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31CAD -53.44745.7%
20242024-03-31CAD -6.52-87.8%
20252025-03-31CAD -3.40-47.8%
20262026-03-31CAD -0.64-81.2%
Canopy Growth sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-3097.3%
Q32025-12-31-4066.7%
Q42026-03-31-60.0%
Q12026-06-3092.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2027YOY CHG

Revenue

CA$81.17M

+12.5%

Gross Profit

CA$22.24M

+23.3%

Gross Margin

27.40%

N/A

Market Cap

$431.50MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$382.53K

N/A

Employees

1,128

N/A

Net Income

-CA$14.58M

+64.9%

EBITDA

-CA$4.67M

+78.6%

Quarterly Fundamentals

Name
Q1 2027YOY CHG

Total Cash

CA$341.68M

+137.9%

Total Debt

CA$277.33M

-15.4%

Accounts Receivable

CA$42.59M

-14.9%

Inventory

CA$107.46M

+14.5%

Long Term Debt

CA$234.26M

-24.2%

Short Term Debt

CA$43.07M

+127.6%

Return on Assets

-21.43%

N/A

Return on Invested Capital

-16.01%

N/A

Free Cash Flow

-CA$25.75M

-117.7%

Operating Cash Flow

-CA$25.01M

-142.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CABACabaletta Bio, Inc.
$2.89+5.09%
BIOABioAge Labs Inc.
$10.40-1.89%
TKNOAlpha Teknova, Inc.
$7.22-0.96%
LYELLyell Immunopharma, Inc.
$13.55-2.87%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.61-0.02%
SPCXSpace Exploration Technologies
$146.23+0.04%
IPSTIp Strategy
$7.39+2.36%
NVDANvidia
$225.01-0.00%

Questions About CGC

What is the current price of Canopy Growth?

Canopy Growth is trading at $1.00 per share.

What is the 52-week range for Canopy Growth?

Over the past 52 weeks, Canopy Growth has traded between $0.84 and $2.38.

How much debt does Canopy Growth have?

As of the most recent reporting period, Canopy Growth reported total debt of CA$195.47M.

How much cash does Canopy Growth have on hand?

Canopy Growth reported CA$237.27M in cash and cash equivalents in its most recent financial results.

What is Canopy Growth’s dividend yield?

Canopy Growth does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services